TGFB1 and colonic neoplasm: In contrast, in two papillary thyroid carcinoma cell lines, miR-663 behaved as a tumor-suppressor by targeting TGFβ1, thus inhibiting epithelium-to-mesenchyme transition [51], similar to what was previously found in SW480 colon cancer cells [28].